Joseph Dycoco

Joseph Dycoco

Auto-generated profile, based on publicly available information

Joseph Dycoco

Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
RFRaja M. Flores
Raja M. Flores
HPHarvey Pass
Harvey Pass
VSVenkatraman E. Seshan
Venkatraman E. Seshan
JDJoseph Dycoco
Joseph Dycoco
MZMaureen Zakowski
Maureen Zakowski
VRValerie W. Rusch
Valerie W. Rusch

1 July 2009 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
RFRaja M. Flores
Raja M. Flores
BPBernard J. Park
Bernard J. Park
JDJoseph Dycoco
Joseph Dycoco
AAAnna Aronova
Anna Aronova
YHYael Hirth
Yael Hirth
VRValerie W. Rusch
Valerie W. Rusch

1 January 2013 in The Journal of Thoracic and Cardiovascular Surgery
Verified
Journal Article
Closed access
FLFeiran Lou
Feiran Lou
JHJames Huang
James Huang
CSCamelia S. Sima
Camelia S. Sima
JDJoseph Dycoco
Joseph Dycoco
VRValerie Rusch
Valerie Rusch
PBPeter B. Bach
Peter B. Bach

1 October 2007 in Journal of Thoracic Oncology
Verified
Journal Article
Open access
PDF file
RFRaja M. Flores
Raja M. Flores
MZMaureen Zakowski
Maureen Zakowski
EVEnnapadam Venkatraman
Ennapadam Venkatraman
LKLee Krug
Lee Krug
KRKenneth Rosenzweig
Kenneth Rosenzweig
VRValerie Rusch
Valerie Rusch
The treatment of malignant pleural mesothelioma (MPM) has evolved in the past 20 years. Although controversy still exists with regard to standard care, significant advances have been made in diagnosis, imaging, staging, patient selection, chemotherapy, surgical technique, and radiotherapy. Before 1990, pathologic diagnosis was less precise. Therefore, older series included adenocarcinomas and sarcomas inadvertently diagnosed as epithelioid and sarcomatoid mesotheliomas, respectively, leading to inaccurate survival information. Table 1 Table 1 shows some of the largest and most relevant studies in MPM.1 x 1 Ruffie, P, Feld, R, Minkin, S et al. Diffuse malignant mesothelioma of the pleura in Ontario and Quebec: a retrospective study of 322 patients. J Clin Oncol. 1989; 7: 1157–1168 Crossref | PubMed | Scopus (299) | Google Scholar See all References , 2 x 2 Alberts, AS, Falkson, G, Goedhals, L et al. Malignant pleural mesothelioma: a disease unaffected by current therapeutic maneuvers. J Clin Oncol. 1988; 6: 527–535 Crossref | PubMed | Scopus (191) | Google Scholar See all References , 3 x 3 Butchart, E, Ashcroft, T, Barnsley, W et al. Pleuropneumonectomy in the management of diffuse malignant mesothelioma of the pleura: experience with 29 patients. Thorax. 1976; 31: 15–24 Crossref | PubMed | Scopus (379) | Google Scholar See all References , 4 x 4 Sugarbaker, DJ, Flores, RM, Jaklitsch, MT et al. Resection margins, extrapleural nodal status, and cell type determine postoperative long- term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients. J Thorac Cardiovasc Surg. 1999; 117: 54–65 Abstract | Full Text | Full Text PDF | PubMed | Scopus (730) | Google Scholar See all References , 5 x 5 Rusch, VW and Venkatraman, ES. Important prognostic factors in patients with malignant pleural mesothelioma, managed surgically. Ann Thorac Surg. 1999; 68: 1799–1804 Abstract | Full Text | Full Text PDF | PubMed | Scopus (192) | Google Scholar See all References , 6 x 6 Herndon, JE, Green, MR, Chahinian, AP, Corson, JM, Suzuki, Y, and Vogelzang, NJ. Factors predictive of survival among 337 patients with mesothelioma treated between 1984 and 1994 by the Cancer and Leukemia Group B. Chest. 1998; 113: 723–731 Crossref | PubMed | Scopus (366) | Google Scholar See all References , 7 x 7 Aziz, T, Jilaihawi, A, and Prakash, D. The management of malignant pleural mesothelioma; single centre experience in 10 years. Eur J Cardiothorac Surg. 2002; 22: 298–305 Crossref | PubMed | Scopus (96) | Google Scholar See all References , 8 x 8 Lee, TT, Everett, DL, Shu, HG et al. Radical pleurectomy/decortication and intraoperative radiotherapy followed by conformal radiation with or without chemotherapy for malignant pleural mesothelioma. J Thorac Cardiovasc. 2002; 124: 1183–1189 Abstract | Full Text | Full Text PDF | PubMed | Scopus (87) | Google Scholar See all References , 9 x 9 Maggi, G, Casadio, C, Cianci, R, Rena, O, and Ruffini, E. Trimodality management of malignant pleural mesothelioma. Eur J Cardiothorac Surg. 2001; 19: 346–350 Crossref | PubMed | Scopus (66) | Google Scholar See all References , 10 x 10 Vogelzang, NJ, Rusthoven, JJ, Symanowski, J et al. Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol. 2003; 21: 2636–2644 Crossref | PubMed | Scopus (1868) | Google Scholar See all References

1 June 2009 in The Annals of Thoracic Surgery
Verified
Journal Article
Closed access
MOMark W. Onaitis
Mark W. Onaitis
RPRebecca P. Petersen
Rebecca P. Petersen
JHJohn C. Haney
John C. Haney
LSLeonard Saltz
Leonard Saltz
BPBernard Park
Bernard Park
RDRobert Downey
Robert Downey

1 December 2012 in Journal of Thoracic Oncology
Verified
Journal Article
Closed access
PDF file
SDSandra P. D’aNgelo
Sandra P. D’aNgelo
YJYelena Y. Janjigian
Yelena Y. Janjigian
NANicholas Ahye
Nicholas Ahye
GRGregory J. Riely
Gregory J. Riely
JCJamie E. Chaft
Jamie E. Chaft
CAChristopher G. Azzoli
Christopher G. Azzoli